Browsing: Ultragenyx

FollowQ1: 2026-05-05 Earnings SummaryEPS of -$1.54 misses by $0.08  | Revenue of $136.00M (-2.36% Y/Y) misses by $19.87M Ultragenyx Pharmaceutical Inc. (RARE) Q1 2026 Earnings Call May…

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.U.S. stocks opened 2026…